# Ulrike Schara, M.D. – FDA Inspection, Aug 4, 2017

Source: https://www.keypedia.com/records/fda_inspections/ulrike-schara-md/e678ca2a-e9ce-4859-840e-b9a1aa88f642
Source feed: FDA_Inspections

> FDA inspection 1021225 of Ulrike Schara, M.D., August 04, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021225
- Company Name: Ulrike Schara, M.D.
- Inspection Date: 2017-08-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Company Rep](https://www.keypedia.com/people/craig-t-rybus/246aad79-6370-42e2-af6e-c0079c1bcbc6)
- [Company Rep](https://www.keypedia.com/people/sherri-n-rohlf/41090ab1-83d1-4e95-92ea-0cfca5cecdb6)

Company: https://www.keypedia.com/companies/ulrike-schara-md/17daadb8-3b91-447d-a318-e6817a1629bd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c